Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/29/1998US5854025 IGF-II analogues
12/29/1998US5854023 Polynucleotides encoding human S-adenosyl-5-homocysteine hydrolase derived from bladder
12/29/1998US5854022 Polynucleotides encoding a CD53-like transmembrane protein
12/29/1998US5854020 TCSTS polynucleotides
12/29/1998US5854016 Creba Isoform
12/29/1998US5854003 Screening method for agents that modulate human NIK activity
12/29/1998US5854001 Hepatitis C virus fusion proteins
12/29/1998US5853999 Methods of screening for agents that inhibit interaction between MHC class I antigens and a cell surface receptor
12/29/1998US5853997 Human protein phosphatase
12/29/1998US5853987 Decorin binding protein compositions and methods of use
12/29/1998US5853975 Methods for identifying compositions for the treatment of body weight disorders, including obesity
12/29/1998US5853763 Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release
12/29/1998US5853748 Pharmaceutical compositions
12/29/1998US5853746 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
12/29/1998US5853739 Transmission-blocking vaccine against malaria
12/29/1998US5853723 Targeting of peg antibody conjugates to islet cells
12/29/1998US5853716 Genetically engineered chimeric viruses for the treatment of diseases associated with viral transactivators
12/29/1998US5853713 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
12/29/1998US5853697 Methods of treating established colitis using antibodies against IL-12
12/29/1998US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
12/29/1998CA2171281C Immunomodulating compositions from bile
12/29/1998CA2150265C Activation of p53 protein
12/29/1998CA2148689C Treatment of infertility and enhancement of fertilization capacity in mammalian males
12/29/1998CA2130995C Method for treating macrophage pathogen infections
12/29/1998CA2129554C Recombinant antibodies specific for tnf-.alpha.
12/29/1998CA1340297C Conjugation of polymer to colony stimulating factor-1
12/29/1998CA1340296C Cell growth regulatory factor
12/29/1998CA1340295C Human somatomedin carrier protein subunits and process for procucing them
12/29/1998CA1340289C Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
12/29/1998CA1340288C Generation and selection of novel binding proteins
12/27/1998CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/26/1998CA2235778A1 Novel glmu
12/24/1998DE19736198C1 Protease related protein
12/24/1998DE19726255A1 Beeinflussung von Cytokinen durch proteolytische Enzyme Influence of cytokines by proteolytic enzymes
12/24/1998DE19726254A1 Toleranzinduktion durch Proteasen Tolerance induction by proteases
12/24/1998DE19726253A1 Verwendung von mindestens einem proteolytischen Enzym zur Behandlung von Glomerulonephritis Use of at least a proteolytic enzyme for the treatment of glomerulonephritis
12/24/1998DE19726251A1 Verwendung proteolytischer Enzyme zur Behandlung von Uveitis The use of proteolytic enzymes for the treatment of uveitis
12/24/1998DE19726248A1 Verwendung proteolytischer Enzyme zur Behandlung von septischem Schock The use of proteolytic enzymes in the treatment of septic shock
12/24/1998DE19726244A1 Verwendung proteolytischer Enzyme zur Vorbeugung bzw. Behandlung der Transplantatabstoßung The use of proteolytic enzymes to prevent or treat graft rejection
12/24/1998DE19725186A1 Herz- und Skelettmuskel-spezifische Nukleinsäure, ihre Herstellung und Verwendung Heart and skeletal muscle-specific nucleic acid, their preparation and use
12/24/1998DE19724696A1 Pharmazeutische Zubereitung mit drei Pelletarten Pharmaceutical composition with three pellet types
12/24/1998DE19724458A1 Use of proteolytic enzymes e.g., trypsin, bromelain or papain
12/24/1998CA2234418A1 Human afc1
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998058080A1 A method for in vitro molecular evolution of protein function
12/23/1998WO1998058066A1 New human lysophospholipase
12/23/1998WO1998058064A1 Kinesin-related protein
12/23/1998WO1998058062A1 Apo-2DcR
12/23/1998WO1998058059A1 Lag-3 splice variants
12/23/1998WO1998058058A1 Hammerhead ribozymes with extended cleavage rule
12/23/1998WO1998058057A1 Compositions inducing cleavage of rna motifs
12/23/1998WO1998058056A1 Cartilage growth agent
12/23/1998WO1998058055A2 Antisense nucleic acids targeting hbv
12/23/1998WO1998058052A2 Disease associated protein kinases
12/23/1998WO1998058051A1 Transgenically produced prolactin
12/23/1998WO1998057994A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
12/23/1998WO1998057993A1 Secretory immunoglobulin produced by single cells and methods for making and using same
12/23/1998WO1998057991A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057990A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
12/23/1998WO1998057987A2 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998WO1998057986A2 Human preprotachykinin b
12/23/1998WO1998057984A2 Torsin, torsin genes, and methods of use
12/23/1998WO1998057982A2 Aib1, a steroid receptor co-activator
12/23/1998WO1998057980A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057979A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057976A1 Secreted proteins and polynucleotides encoding them
12/23/1998WO1998057678A2 Compositions containing thrombin and microfibrillar collagen
12/23/1998WO1998057664A1 Interleukin converting enzyme (ice) and central nervous system damage
12/23/1998WO1998057663A1 Neural transplantation for treating neurological disease
12/23/1998WO1998057657A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998WO1998057656A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
12/23/1998WO1998057655A1 A method of enhancing antigen-specific peripheral immune tolerance
12/23/1998WO1998057653A1 An oral care composition comprising a bacillus pullulanase and a dextranase
12/23/1998WO1998057636A1 Treatment of diabetes with rosiglitazone and insulin
12/23/1998WO1998057621A1 Angiogenic modulation by notch signal transduction
12/23/1998WO1998044098A3 Strl33, a human fusion accessory factor associated with hiv infection
12/23/1998WO1998042868A3 Screening method for proline-rich proteins
12/23/1998WO1998042830A3 Noey2 gene compositions and methods of use
12/23/1998WO1998042741A3 Secreted proteins and polynucleotides encoding them
12/23/1998WO1998041535A3 Activation of peptides
12/23/1998WO1998039446A3 70 human secreted proteins
12/23/1998WO1998038211A3 Permuted hemoglobin-like proteins
12/23/1998EP0885966A2 Novel compouds
12/23/1998EP0885965A2 Histidine kinase polypeptides
12/23/1998EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide
12/23/1998EP0885961A1 Novel insulin derivatives with rapid onset of action
12/23/1998EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998EP0885959A2 Human Wnt-5b protein
12/23/1998EP0885956A1 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro) biological production of proteins
12/23/1998EP0885904A1 Peptides as agonists and/or inhibitors of amyloid formation and/or cytotoxicity and their use against Alzheimer's disease, type II diabetes mellitus and spongiform encephalopathy
12/23/1998EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator
12/23/1998EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
12/23/1998EP0885901A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
12/23/1998EP0885900A2 Increasing blood-brain barrier permeability with permeabilizer peptide derivatives of bradykinin
12/23/1998EP0885887A2 Sulfonamide inhibitors of HIV-Aspartyl protease
12/23/1998EP0885613A1 Use of modified hemoglobins for treatment of anemias and erythropoietin and modified hemoglobin containing combined preparations
12/23/1998EP0885608A1 Remedies for brain diseases
12/23/1998EP0885392A1 Process for diagnosing alzheimer's disease and agents for use in therapy
12/23/1998EP0885309A1 Direct molecular diagnosis of friedreich ataxia
12/23/1998EP0885308A1 Compositions and methods of making embryonic stem cells
1 ... 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 ... 3163